Abstract:CRISPR-Cas12a (previously named Cpf1) is a prokaryotic deoxyribonuclease that can be programmed with an RNA guide to target complementary DNA sequences. Upon binding of the target DNA, Cas12a induces a nick in each of the target DNA strands, yielding a double-stranded DNA break. In addition to inducing cis-cleavage of the targeted DNA, target DNA binding induces trans-cleavage of non-target DNA. As such, Cas12a-RNA guide complexes can provide sequence-specific immunity against invading nucleic acids such as bacteriophages and plasmids. Akin to CRISPR-Cas9, Cas12a has been repurposed as a genetic tool for programmable genome editing and transcriptional control in both prokaryotic and eukaryotic cells. In addition, its trans-cleavage activity has been applied for high-sensitivity nucleic acid detection. Despite the demonstrated value of Cas12a for these applications, the exact molecular mechanisms of both cis- and trans-cleavage of DNA were not completely understood. Recent studies have revealed mechanistic details of Cas12a-mediates DNA cleavage: base pairing of the RNA guide and the target DNA induces major conformational changes in Cas12a. These conformational changes render Cas12a in a catalytically activated state in which it acts as deoxyribonuclease. This deoxyribonuclease activity mediates cis-cleavage of the displaced target DNA strand first, and the RNA guide-bound target DNA strand second. As Cas12a remains in the catalytically activated state after cis-cleavage, it subsequently demonstrates trans-cleavage of non-target DNA. Here, I review the mechanistic details of Cas12a-mediated cis- and trans-cleavage of DNA. In addition, I discuss how bacteriophage-derived anti-CRISPR proteins can inhibit Cas12a activity.

The trans DNA cleavage activity of Cas12a provides no detectable immunity against plasmid or phage

Making the cut(s): how Cas12a cleaves target and non-target DNA

A naturally DNase-free CRISPR-Cas12c enzyme silences gene expression

A type III-A CRISPR–Cas system mediates co-transcriptional DNA cleavage at the transcriptional bubbles in close proximity to active effectors

The ribonuclease activity of Csm6 is required for anti-plasmid immunity by Type III-A CRISPR-Cas systems

Highly Efficient DNA Reporter for CRISPR/Cas12a-Based Specific and Sensitive Biosensor

The Bridge Helix of Cas12a Imparts Selectivity in Cis-Dna Cleavage and Regulates Trans-Dna Cleavage.

The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA

Trans Single‐Stranded DNA Cleavage Via CRISPR/Cas14a1 Activated by Target RNA Without Destruction

Structural insights into target DNA recognition and cleavage by the CRISPR-Cas12c1 system

Large-scale structural rearrangements unleash indiscriminate nuclease activity of CRISPR-Cas12a2

Modulation of CRISPR/Cas12a trans-cleavage activity by various DNA-modifying enzymes

Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

RNA targeting unleashes indiscriminate nuclease activity of CRISPR–Cas12a2

Trans -nuclease activity of Cas9 activated by DNA or RNA target binding

Determinants of CRISPR Cas12a nuclease activation by DNA and RNA targets

The Cas6e ribonuclease is not required for interference and adaptation by the E. coli type I-E CRISPR-Cas system

An anti-CRISPR protein disables type V Cas12a by acetylation

The Cas10 nuclease activity relieves host dormancy to facilitate spacer acquisition and retention during type III-A CRISPR immunity

tRNA anticodon cleavage by target-activated CRISPR-Cas13a effector

CRISPR-Cas9 target-strand nicking provides phage resistance by inhibiting replication